Atlas Trials

Mirabegron and Oxybutynin Safety and Efficacy Trial in Spinal Cord Injury

Clinical trial NCT03187795 · UNKNOWN

Trial details

NCT number
NCT03187795
Sponsor
Kessler Foundation
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Spinal Cord InjuriesUrinary Bladder, Neurogenic
Start date
2019-04-03
Primary completion
2021-09-30
Enrollment
62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.